Lead Product(s) : Rozanolixizumab
Therapeutic Area : Musculoskeletal
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibody
Upfront Cash : Inapplicable
December 09, 2022
Lead Product(s) : Rozanolixizumab
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : GLPG1972
Therapeutic Area : Musculoskeletal
Study Phase : Phase II
Sponsor : Servier
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Assess Efficacy and Safety of GLPG1972/S201086 in Participants With Knee Osteoarthritis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 23, 2018
Lead Product(s) : GLPG1972
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase II
Sponsor : Servier
Deal Size : Inapplicable
Deal Type : Inapplicable